Standard Oral Rehydration — Competitive Intelligence Brief

Standard Oral Rehydration (Standard Oral Rehydration) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte replacement solution. Area: Gastroenterology / Emergency Medicine.

marketed Electrolyte replacement solution Gastroenterology / Emergency Medicine Small molecule

Target snapshot

Standard Oral Rehydration (Standard Oral Rehydration) — Federico II University. Standard Oral Rehydration Solution (ORS) replaces water and electrolytes lost through dehydration by providing a balanced mixture of glucose, sodium, potassium, and chloride for intestinal absorption.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Standard Oral Rehydration TARGET	Standard Oral Rehydration	Federico II University	marketed	Electrolyte replacement solution
Plegisol In Plastic Container	Calcium Chloride	Pfizer	marketed	Electrolyte replacement solution	Electrolyte balance and fluid homeostasis	1971-01-01
Saline solution isotonic 0.9% NaCl	Saline solution isotonic 0.9% NaCl	Krankenhaus Barmherzige Schwestern Linz	marketed	Crystalloid fluid / Electrolyte replacement solution
Plasma-lyte (dynamic group)	Plasma-lyte (dynamic group)	Algemeen Ziekenhuis Maria Middelares	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution
Normal Saline 0.9% Infusion Solution Bag	Normal Saline 0.9% Infusion Solution Bag	Vanderbilt University Medical Center	marketed	Crystalloid fluid / Electrolyte replacement solution
Isotonic sodium chloride 0.9 percent	Isotonic sodium chloride 0.9 percent	Rigshospitalet, Denmark	marketed	Crystalloid fluid / Electrolyte replacement solution
Intravenous 0.9% Sodium Chloride	Intravenous 0.9% Sodium Chloride	GCP-Service International West GmbH	marketed	Crystalloid fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte replacement solution class)

1. Baxter Healthcare Corporation · 1 drug in this class
2. Centre Hospitalier Universitaire Dijon · 1 drug in this class
3. Centre Hospitalier Universitaire de Nice · 1 drug in this class
4. Department of Medical Services Ministry of Public Health of Thailand · 1 drug in this class
5. Federico II University · 1 drug in this class
6. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
7. Nepal Health Research Council · 1 drug in this class
8. Pfizer · 1 drug in this class
9. Shanghai Hengrui Pharmaceutical Co., Ltd. · 1 drug in this class
10. TC Erciyes University · 1 drug in this class